|
Cabello MJ, Grau L, Franco N, Orenes E, Alvarez M, Blanca A, Heredero O, Palacios A, Urrutia M, Fernández JM, López-Beltrán A, Sánchez-Carbayo M. Multiplexed methylation profiles of tumor suppressor genes in bladder cancer. J Mol Diagn. 2011 Jan;13(1):29-40. doi: 10.1016/j.jmoldx.2010.11.008. Epub 2010 Dec 23. PubMed PMID: 21227392; PubMed Central PMCID: PMC3070573.
AÑO: 2011; IF: 3.576
|
21227392
|
Aleman A, Cebrian V, Alvarez M, Lopez V, Orenes E, Lopez-Serra L, Algaba F, Bellmunt J, López-Beltrán A, Gonzalez-Peramato P, Cordon-Cardo C, García J, del Muro JG, Esteller M, Sánchez-Carbayo M. Identification of PMF1 methylation in association with bladder cancer progression. Clin Cancer Res. 2008 Dec 15;14(24):8236-43. doi: 10.1158/1078-0432.CCR-08-0778. PubMed PMID: 19088041.
AÑO: 2008; IF: 6.488
|
|
Orenes-Piñero E, Hernández-Romero D, Romero-Aniorte AI, Martínez M, García-Honrubia A, Caballero L, Garrigos-Gómez N, Andreu-Cayuelas JM, González J, Feliu E, Climent V, Nicolás-Ruiz F, De La Morena G, Valdés M, Lip GY, Marín F. Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy. QJM. 2014 Aug;107(8):613-21. doi: 10.1093/qjmed/hcu046. PubMed PMID: 24599807.
AÑO: 2014; IF: 2.495
|
|
Hernández-Romero D, Jover E, Martínez CM, Andreu-Cayuelas JM, Orenes-Piñero E, Romero-Aniorte AI, Casas T, Cánovas S, Montero-Argudo JA, Valdés M, de la Morena G, Marín F. TWEAK and NT-proBNP levels predict exercise capacity in hypertrophic cardiomyopathy. Eur J Clin Invest. 2015 Feb;45(2):179-86. doi: 10.1111/eci.12394. PubMed PMID: 25524713.
AÑO: 2015; IF: 2.687
|
|
Navas-Carrillo D, Ríos A, Rodríguez JM, Parrilla P, Orenes-Piñero E. Familial nonmedullary thyroid cancer: screening, clinical, molecular and genetic findings. Biochim Biophys Acta. 2014 Dec;1846(2):468-76. doi: 10.1016/j.bbcan.2014.09.002. Review. PubMed PMID: 25218916.
AÑO: 2014; IF: 7.845
|